Objective: The purpose of this literature review is to explore the non-invasive and cost-efficient technology of the bubble CPAP (bCPAP) in neonates to encourage respiratory success in the hours following birth. This intervention is explored in regard to safety and extubation success in comparison to other continuous positive airway pressure devices to promote best practice and safety for patients.
Findings: bCPAP is an effective and safe alternative to help treat respiratory insufficiency in premature neonates. Utilization of bCPAP for premature neonates as a non-invasive respiratory support system has many benefits. These include decreased extubation failure, increased survival rates, improved Silverman Andersen respiratory severity scores, and a decreased need for mechanical ventilation. Success of the intervention is further validated by SpO2 levels, O2 requirement, signs and symptoms of respiratory distress, and rate of breathing. The positive results of bCPAP can be correlated with the early application of the intervention immediately after birth and continuous monitoring to further adjust the device settings to meet the specific needs of the patient. Risk factors of this intervention include skin breakdown and nasal septal injury, which must be monitored. Some of the literature is from underserved populations due to the easy accessibility and low cost as compared to other methods.
Conclusion: The intervention of bCPAP is an effective alternative to other forms of continuous positive airway pressure devices and mechanical ventilation as it provides improved patient outcomes, decreased costs, and is minimally invasive.
See more of: Invited Posters